Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Postoperative Delirium in Elderly Patients (ELEMENT)
NCT06817239Recruiting
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Feb 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of esketamine in delirium (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoints: Incidence of delirium within 5 days after surgery and Quality of recovery on postoperative day 1. Started Feb 2025; status: recruiting.
02
Drugs
esketamine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT06817239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06817239.